Onward Medical has started a Netherlands-based clinical feasibility study to assess its ARC-IM neurostimulator’s ability to improve haemodynamic instability in spinal cord injury (SCI)...
Photobiomodulation device firm, LumiThera, has announced the launch of a new clinical registry study designed to collect safety and efficacy data from patients living...
Astent system designed by Reflow Medical to treat de novo or restenotic lesions in the infrapopliteal arteries has been awarded a CE mark.
US-based cardiovascular...
The US Food and Drug Administration (FDA) has granted investigational device exemption (IDE) approval for Endovascular Engineering’s trial investigating its Hēlo Thrombectomy System in...
US-based Nexalin Technology has unveiled a third-generation HALO Clarity 15 milliamp (mA) neurostimulation device.
The company plans to conduct decentralised clinical trials for the HALO...
Neuralace Medical has received US Food and Drug Administration (FDA) clearance of Axon Therapy to treat chronic Painful Diabetic Neuropathy (PDN).
Related: 3Spine completes enrolment...
Biosensor company Zedzen has partnered with the Imperial College Healthcare NHS Trust to conduct a clinical study investigating its non-invasive sensing device.
The DiCET clinical...
US-based Cardionomic has completed the patient enrolment in its two pilot studies, STIM-ADHF and STOP-ADHF, evaluating the cardiac pulmonary nerve stimulation (CPNS) system in...
